NR1H4 and breast cancer: Downregulated pathways included those involved in suppressing proliferation and/or increasing apoptosis of breast cancer cells [i.e., farnesoid X receptor (FXR)/retinoid X receptor (RXR) activation, liver X receptor (LXR)/RXR activation) and classical inflammatory processes (i.e., coagulation system, acute phase response signaling).